Candel Therapeutics, Inc. (CADL)

7.53 +1.06 (+16.38%) USD  |  NASDAQ  |  May 04, 16:00
7.56 +0.03 (+0.40%) After-Hours: 18:47
More

Candel Therapeutics Operating Income (Annual)

Operating Income (Annual) Chart

View Operating Income (Annual) for CADL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Annual) Range, Past 5 Years

View Operating Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Annual) Benchmarks

View Operating Income (Annual) Benchmarks
Start Trial
Oncolytics Biotech, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade